Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
58.9M
-
Number of holders
-
166
-
Total 13F shares, excl. options
-
54.6M
-
Shares change
-
+334K
-
Total reported value, excl. options
-
$717M
-
Value change
-
+$6.5M
-
Put/Call ratio
-
5.28
-
Number of buys
-
79
-
Number of sells
-
-72
-
Price
-
$13.14
Significant Holders of Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share (VNDA) as of Q4 2020
185 filings reported holding VNDA - Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share as of Q4 2020.
Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share (VNDA) has 166 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 54.6M shares
of 58.9M outstanding shares and own 92.69% of the company stock.
Largest 10 shareholders include BlackRock Inc. (9.81M shares), ARMISTICE CAPITAL, LLC (5.4M shares), Palo Alto Investors LP (4.23M shares), RENAISSANCE TECHNOLOGIES LLC (3.99M shares), VANGUARD GROUP INC (3.96M shares), STATE STREET CORP (3.2M shares), MACQUARIE GROUP LTD (3.19M shares), DIMENSIONAL FUND ADVISORS LP (1.55M shares), PRUDENTIAL FINANCIAL INC (1.03M shares), and ACADIAN ASSET MANAGEMENT LLC (992K shares).
This table shows the top 166 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.